Cargando…
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
The race to produce vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began when the first sequence was published, and this forms the basis for vaccines currently deployed globally. Independent lineages of SARS-CoV-2 have recently been reported: UK, B.1.1.7; South Africa,...
Ejemplares similares
-
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
por: Supasa, Piyada, et al.
Publicado: (2021) -
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022) -
Antibody evasion by the P.1 strain of SARS-CoV-2
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2021) -
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
por: Liu, Chang, et al.
Publicado: (2022) -
Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
por: Dijokaite-Guraliuc, Aiste, et al.
Publicado: (2022)